Product Code: ETC5306133 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Pneumonia Vaccine Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Serbia Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Serbia Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Serbia Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Serbia Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Serbia Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Rising prevalence of pneumonia in Serbia |
4.2.3 Government initiatives to improve vaccination coverage |
4.3 Market Restraints |
4.3.1 High cost associated with pneumonia vaccines |
4.3.2 Limited accessibility to vaccines in remote areas of Serbia |
4.3.3 Lack of healthcare infrastructure and resources |
5 Serbia Pneumonia Vaccine Market Trends |
6 Serbia Pneumonia Vaccine Market Segmentations |
6.1 Serbia Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.3 Serbia Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Serbia Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Serbia Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Serbia Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Serbia Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Serbia Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Serbia Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Serbia Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Serbia Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Serbia Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Serbia Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Serbia Pneumonia Vaccine Market Export to Major Countries |
7.2 Serbia Pneumonia Vaccine Market Imports from Major Countries |
8 Serbia Pneumonia Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage among high-risk populations |
8.2 Number of government-funded vaccination programs implemented |
8.3 Improvement in healthcare infrastructure to support vaccination campaigns |
8.4 Number of reported cases of pneumonia in Serbia |
8.5 Percentage of healthcare professionals trained in administering pneumonia vaccines |
9 Serbia Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Serbia Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Serbia Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Serbia Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Serbia Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Pneumonia Vaccine Market - Competitive Landscape |
10.1 Serbia Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Serbia Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |